TEVA 8199 TEVA 8199 Pill - maroon capsule/oblong, 14mm
Pill with imprint TEVA 8199 TEVA 8199 is Maroon, Capsule/Oblong and has been identified as Sunitinib Malate 12.5 mg. It is supplied by Teva Pharmaceuticals USA, Inc.
Sunitinib is used in the treatment of Renal Cell Carcinoma; Gastrointestinal Stromal Tumor; Pancreatic Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 8199 TEVA 8199
Sunitinib Malate
- Imprint
- TEVA 8199 TEVA 8199
- Strength
- 12.5 mg
- Color
- Maroon
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00093-8199
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
mannitol,
povidone k30,
D&C Red No. 28,
FD&C Blue No. 1,
FD&C Red No. 40,
gelatin,
titanium dioxide,
ferrosoferric oxide,
D&C Yellow No. 10 Aluminium Lake,
FD&C Blue No. 1 Aluminium Lake,
FD&C Blue No. 2 Aluminium Lake,
shellac,
propylene glycol
Note: Inactive ingredients may vary.
More about sunitinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.